Evaluation of efficacy of whey protein in contact dermatitis

Evaluation of efficacy of whey protein in improving the symptoms of patients with contact dermatitis: A randomized double blind placebo, control clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190202042587N1

Enrollment

Registered

2019-03-03

Start date

2019-03-06

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contact dermatitis. Unspecified contact dermatitis

Interventions

Intervention 1: Intervention group: Patients will receive 30 grams of powder per day, orally, from reputable pharmaceutical companies(half the dose in children) divided into two equal doses. Interven

Eligibility

Sex/Gender

All

Age

5 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 5 years Contact dermatitis(clinical or with patch test)

Exclusion criteria

Exclusion criteria: Cows milk allergy Pregnancy or severe disease as malignancy Patients who had a new treatment or an increase in the dose within 4 weeks prior to the intervention Patients treated with immunosuppressive drugs

Design outcomes

Primary

Measure	Time frame
Reduced scores in questionnaire and during periodic examination, which indicate better control of the disease and reduced symptoms. Timepoint: At the beginning of the study, 14 and 28 days after starting the drug. Method of measurement: Questionnaire including EASI (eczema area and severity index) and VAS (visual analog scale) and DLQ index (dermatology life quality index).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyed Mohammad Hashemi

Shiraz University of Medical Sciences

smhashemi5@gmail.com+98 71 3612 5401

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026